BiVictriX Therapeutics PLC
LSE:BVX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BiVictriX Therapeutics PLC
LSE:BVX
|
UK |
|
J
|
Jet.AI Inc
NASDAQ:JTAI
|
US |
|
Jupiter Fund Management PLC
F:4JF
|
UK |
|
W
|
WEIli Holdings Ltd
HKEX:2372
|
CN |
|
C
|
CowinTech Co Ltd
KOSDAQ:282880
|
KR |
|
F
|
Fraser & Neave Holdings Bhd
KLSE:F&N
|
MY |
|
Alamo Group Inc
NYSE:ALG
|
US |
Income Statement
Earnings Waterfall
BiVictriX Therapeutics PLC
Income Statement
BiVictriX Therapeutics PLC
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(2)
N/A
|
(3)
-76%
|
(3)
-13%
|
(3)
+5%
|
(3)
-7%
|
(3)
-7%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
(1)
|
(1)
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(4)
-44%
|
(3)
+18%
|
(3)
+5%
|
(3)
-7%
|
(3)
-7%
|
|
| Net Income | |||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Income from Continuing Operations |
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Net Income (Common) |
(2)
N/A
|
(3)
-38%
|
(2)
+23%
|
(2)
+7%
|
(3)
-9%
|
(3)
-5%
|
|
| EPS (Diluted) |
-0.06
N/A
|
-0.05
+17%
|
-0.04
+20%
|
-0.04
N/A
|
-0.04
N/A
|
-0.04
N/A
|
|